img

Global GABA Receptor Agonist Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global GABA Receptor Agonist Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

GABA Receptor Agonist Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global GABA Receptor Agonist Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Attention Deficit Hyperactivity Disorder (ADHD) and Psychiatric Disorders and Depression are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for GABA Receptor Agonist Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, GABA Receptor Agonist Drug key manufacturers include Advicenne, AstraZeneca, Athena Drug Delivery Solutions, Biocodex, Elan Corporation, Eli Lilly and Company, H.LundBeck, Merck and Co, GlaxoSmithKline and NovaDel Pharma, etc. Advicenne, AstraZeneca, Athena Drug Delivery Solutions are top 3 players and held % sales share in total in 2022.
GABA Receptor Agonist Drug can be divided into Bamaluzole, Phenibut, Baclofen and Gaboxadol, etc. Bamaluzole is the mainstream product in the market, accounting for % sales share globally in 2022.
GABA Receptor Agonist Drug is widely used in various fields, such as Attention Deficit Hyperactivity Disorder (ADHD), Psychiatric Disorders and Depression, Alzheimer and Epilepsy and Seizure, etc. Attention Deficit Hyperactivity Disorder (ADHD) provides greatest supports to the GABA Receptor Agonist Drug industry development. In 2022, global % sales of GABA Receptor Agonist Drug went into Attention Deficit Hyperactivity Disorder (ADHD) filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global GABA Receptor Agonist Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Advicenne
AstraZeneca
Athena Drug Delivery Solutions
Biocodex
Elan Corporation
Eli Lilly and Company
H.LundBeck, Merck and Co
GlaxoSmithKline
NovaDel Pharma
Novartis
OVATION Pharmaceuticals
Osmotica Pharmaceutical
Pfizer
sanofi-aventis
VIVUS
XenoPort
Segment by Type
Bamaluzole
Phenibut
Baclofen
Gaboxadol
Klonopin (clonazepam)
Tiagbine

Segment by Application


Attention Deficit Hyperactivity Disorder (ADHD)
Psychiatric Disorders and Depression
Alzheimer
Epilepsy and Seizure
Anxiety and Sleep Disorders
Obesity and Alcoholism

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the GABA Receptor Agonist Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of GABA Receptor Agonist Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the GABA Receptor Agonist Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of GABA Receptor Agonist Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, GABA Receptor Agonist Drug introduction, etc. GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of GABA Receptor Agonist Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 GABA Receptor Agonist Drug Market Overview
1.1 GABA Receptor Agonist Drug Product Overview
1.2 GABA Receptor Agonist Drug Market Segment by Type
1.2.1 Bamaluzole
1.2.2 Phenibut
1.2.3 Baclofen
1.2.4 Gaboxadol
1.2.5 Klonopin (clonazepam)
1.2.6 Tiagbine
1.3 Global GABA Receptor Agonist Drug Market Size by Type
1.3.1 Global GABA Receptor Agonist Drug Market Size Overview by Type (2018-2034)
1.3.2 Global GABA Receptor Agonist Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global GABA Receptor Agonist Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America GABA Receptor Agonist Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe GABA Receptor Agonist Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific GABA Receptor Agonist Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America GABA Receptor Agonist Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa GABA Receptor Agonist Drug Sales Breakdown by Type (2018-2024)
2 Global GABA Receptor Agonist Drug Market Competition by Company
2.1 Global Top Players by GABA Receptor Agonist Drug Sales (2018-2024)
2.2 Global Top Players by GABA Receptor Agonist Drug Revenue (2018-2024)
2.3 Global Top Players by GABA Receptor Agonist Drug Price (2018-2024)
2.4 Global Top Manufacturers GABA Receptor Agonist Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 GABA Receptor Agonist Drug Market Competitive Situation and Trends
2.5.1 GABA Receptor Agonist Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by GABA Receptor Agonist Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in GABA Receptor Agonist Drug as of 2022)
2.7 Date of Key Manufacturers Enter into GABA Receptor Agonist Drug Market
2.8 Key Manufacturers GABA Receptor Agonist Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 GABA Receptor Agonist Drug Status and Outlook by Region
3.1 Global GABA Receptor Agonist Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global GABA Receptor Agonist Drug Historic Market Size by Region
3.2.1 Global GABA Receptor Agonist Drug Sales in Volume by Region (2018-2024)
3.2.2 Global GABA Receptor Agonist Drug Sales in Value by Region (2018-2024)
3.2.3 Global GABA Receptor Agonist Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global GABA Receptor Agonist Drug Forecasted Market Size by Region
3.3.1 Global GABA Receptor Agonist Drug Sales in Volume by Region (2024-2034)
3.3.2 Global GABA Receptor Agonist Drug Sales in Value by Region (2024-2034)
3.3.3 Global GABA Receptor Agonist Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global GABA Receptor Agonist Drug by Application
4.1 GABA Receptor Agonist Drug Market Segment by Application
4.1.1 Attention Deficit Hyperactivity Disorder (ADHD)
4.1.2 Psychiatric Disorders and Depression
4.1.3 Alzheimer
4.1.4 Epilepsy and Seizure
4.1.5 Anxiety and Sleep Disorders
4.1.6 Obesity and Alcoholism
4.2 Global GABA Receptor Agonist Drug Market Size by Application
4.2.1 Global GABA Receptor Agonist Drug Market Size Overview by Application (2018-2034)
4.2.2 Global GABA Receptor Agonist Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global GABA Receptor Agonist Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America GABA Receptor Agonist Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe GABA Receptor Agonist Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific GABA Receptor Agonist Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America GABA Receptor Agonist Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa GABA Receptor Agonist Drug Sales Breakdown by Application (2018-2024)
5 North America GABA Receptor Agonist Drug by Country
5.1 North America GABA Receptor Agonist Drug Historic Market Size by Country
5.1.1 North America GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America GABA Receptor Agonist Drug Sales in Volume by Country (2018-2024)
5.1.3 North America GABA Receptor Agonist Drug Sales in Value by Country (2018-2024)
5.2 North America GABA Receptor Agonist Drug Forecasted Market Size by Country
5.2.1 North America GABA Receptor Agonist Drug Sales in Volume by Country (2024-2034)
5.2.2 North America GABA Receptor Agonist Drug Sales in Value by Country (2024-2034)
6 Europe GABA Receptor Agonist Drug by Country
6.1 Europe GABA Receptor Agonist Drug Historic Market Size by Country
6.1.1 Europe GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe GABA Receptor Agonist Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe GABA Receptor Agonist Drug Sales in Value by Country (2018-2024)
6.2 Europe GABA Receptor Agonist Drug Forecasted Market Size by Country
6.2.1 Europe GABA Receptor Agonist Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe GABA Receptor Agonist Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific GABA Receptor Agonist Drug by Region
7.1 Asia-Pacific GABA Receptor Agonist Drug Historic Market Size by Region
7.1.1 Asia-Pacific GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific GABA Receptor Agonist Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific GABA Receptor Agonist Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific GABA Receptor Agonist Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific GABA Receptor Agonist Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific GABA Receptor Agonist Drug Sales in Value by Region (2024-2034)
8 Latin America GABA Receptor Agonist Drug by Country
8.1 Latin America GABA Receptor Agonist Drug Historic Market Size by Country
8.1.1 Latin America GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America GABA Receptor Agonist Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America GABA Receptor Agonist Drug Sales in Value by Country (2018-2024)
8.2 Latin America GABA Receptor Agonist Drug Forecasted Market Size by Country
8.2.1 Latin America GABA Receptor Agonist Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America GABA Receptor Agonist Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa GABA Receptor Agonist Drug by Country
9.1 Middle East and Africa GABA Receptor Agonist Drug Historic Market Size by Country
9.1.1 Middle East and Africa GABA Receptor Agonist Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa GABA Receptor Agonist Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa GABA Receptor Agonist Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa GABA Receptor Agonist Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa GABA Receptor Agonist Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa GABA Receptor Agonist Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Advicenne
10.1.1 Advicenne Company Information
10.1.2 Advicenne Introduction and Business Overview
10.1.3 Advicenne GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Advicenne GABA Receptor Agonist Drug Products Offered
10.1.5 Advicenne Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AstraZeneca GABA Receptor Agonist Drug Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Athena Drug Delivery Solutions
10.3.1 Athena Drug Delivery Solutions Company Information
10.3.2 Athena Drug Delivery Solutions Introduction and Business Overview
10.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Products Offered
10.3.5 Athena Drug Delivery Solutions Recent Development
10.4 Biocodex
10.4.1 Biocodex Company Information
10.4.2 Biocodex Introduction and Business Overview
10.4.3 Biocodex GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Biocodex GABA Receptor Agonist Drug Products Offered
10.4.5 Biocodex Recent Development
10.5 Elan Corporation
10.5.1 Elan Corporation Company Information
10.5.2 Elan Corporation Introduction and Business Overview
10.5.3 Elan Corporation GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Elan Corporation GABA Receptor Agonist Drug Products Offered
10.5.5 Elan Corporation Recent Development
10.6 Eli Lilly and Company
10.6.1 Eli Lilly and Company Company Information
10.6.2 Eli Lilly and Company Introduction and Business Overview
10.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Eli Lilly and Company GABA Receptor Agonist Drug Products Offered
10.6.5 Eli Lilly and Company Recent Development
10.7 H.LundBeck, Merck and Co
10.7.1 H.LundBeck, Merck and Co Company Information
10.7.2 H.LundBeck, Merck and Co Introduction and Business Overview
10.7.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Products Offered
10.7.5 H.LundBeck, Merck and Co Recent Development
10.8 GlaxoSmithKline
10.8.1 GlaxoSmithKline Company Information
10.8.2 GlaxoSmithKline Introduction and Business Overview
10.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 GlaxoSmithKline GABA Receptor Agonist Drug Products Offered
10.8.5 GlaxoSmithKline Recent Development
10.9 NovaDel Pharma
10.9.1 NovaDel Pharma Company Information
10.9.2 NovaDel Pharma Introduction and Business Overview
10.9.3 NovaDel Pharma GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 NovaDel Pharma GABA Receptor Agonist Drug Products Offered
10.9.5 NovaDel Pharma Recent Development
10.10 Novartis
10.10.1 Novartis Company Information
10.10.2 Novartis Introduction and Business Overview
10.10.3 Novartis GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Novartis GABA Receptor Agonist Drug Products Offered
10.10.5 Novartis Recent Development
10.11 OVATION Pharmaceuticals
10.11.1 OVATION Pharmaceuticals Company Information
10.11.2 OVATION Pharmaceuticals Introduction and Business Overview
10.11.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 OVATION Pharmaceuticals GABA Receptor Agonist Drug Products Offered
10.11.5 OVATION Pharmaceuticals Recent Development
10.12 Osmotica Pharmaceutical
10.12.1 Osmotica Pharmaceutical Company Information
10.12.2 Osmotica Pharmaceutical Introduction and Business Overview
10.12.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Osmotica Pharmaceutical GABA Receptor Agonist Drug Products Offered
10.12.5 Osmotica Pharmaceutical Recent Development
10.13 Pfizer
10.13.1 Pfizer Company Information
10.13.2 Pfizer Introduction and Business Overview
10.13.3 Pfizer GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Pfizer GABA Receptor Agonist Drug Products Offered
10.13.5 Pfizer Recent Development
10.14 sanofi-aventis
10.14.1 sanofi-aventis Company Information
10.14.2 sanofi-aventis Introduction and Business Overview
10.14.3 sanofi-aventis GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 sanofi-aventis GABA Receptor Agonist Drug Products Offered
10.14.5 sanofi-aventis Recent Development
10.15 VIVUS
10.15.1 VIVUS Company Information
10.15.2 VIVUS Introduction and Business Overview
10.15.3 VIVUS GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 VIVUS GABA Receptor Agonist Drug Products Offered
10.15.5 VIVUS Recent Development
10.16 XenoPort
10.16.1 XenoPort Company Information
10.16.2 XenoPort Introduction and Business Overview
10.16.3 XenoPort GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 XenoPort GABA Receptor Agonist Drug Products Offered
10.16.5 XenoPort Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 GABA Receptor Agonist Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 GABA Receptor Agonist Drug Industrial Chain Analysis
11.4 GABA Receptor Agonist Drug Market Dynamics
11.4.1 GABA Receptor Agonist Drug Industry Trends
11.4.2 GABA Receptor Agonist Drug Market Drivers
11.4.3 GABA Receptor Agonist Drug Market Challenges
11.4.4 GABA Receptor Agonist Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 GABA Receptor Agonist Drug Distributors
12.3 GABA Receptor Agonist Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Bamaluzole
Table 2. Major Company of Phenibut
Table 3. Major Company of Baclofen
Table 4. Major Company of Gaboxadol
Table 5. Major Company of Klonopin (clonazepam)
Table 6. Major Company of Tiagbine
Table 7. Global GABA Receptor Agonist Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global GABA Receptor Agonist Drug Sales by Type (2018-2024) & (K Pcs)
Table 9. Global GABA Receptor Agonist Drug Sales Market Share in Volume by Type (2018-2024)
Table 10. Global GABA Receptor Agonist Drug Sales by Type (2018-2024) & (US& Million)
Table 11. Global GABA Receptor Agonist Drug Market Share in Value by Type (2018-2024)
Table 12. Global GABA Receptor Agonist Drug Price by Type (2018-2024) & (USD/Pcs)
Table 13. Global GABA Receptor Agonist Drug Sales by Type (2024-2034) & (K Pcs)
Table 14. Global GABA Receptor Agonist Drug Sales Market Share in Volume by Type (2024-2034)
Table 15. Global GABA Receptor Agonist Drug Sales by Type (2024-2034) & (US$ Million)
Table 16. Global GABA Receptor Agonist Drug Sales Market Share in Value by Type (2024-2034)
Table 17. Global GABA Receptor Agonist Drug Price by Type (2024-2034) & (USD/Pcs)
Table 18. North America GABA Receptor Agonist Drug Sales by Type (2018-2024) & (K Pcs)
Table 19. North America GABA Receptor Agonist Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe GABA Receptor Agonist Drug Sales (K Pcs) by Type (2018-2024)
Table 21. Europe GABA Receptor Agonist Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific GABA Receptor Agonist Drug Sales (K Pcs) by Type (2018-2024)
Table 23. Asia-Pacific GABA Receptor Agonist Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America GABA Receptor Agonist Drug Sales (K Pcs) by Type (2018-2024)
Table 25. Latin America GABA Receptor Agonist Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa GABA Receptor Agonist Drug Sales (K Pcs) by Type (2018-2024)
Table 27. Middle East and Africa GABA Receptor Agonist Drug Sales by Type (2018-2024) & (US$ Million)
Table 28. Global GABA Receptor Agonist Drug Sales by Company (2018-2024) & (K Pcs)
Table 29. Global GABA Receptor Agonist Drug Sales Share by Company (2018-2024)
Table 30. Global GABA Receptor Agonist Drug Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global GABA Receptor Agonist Drug Revenue Share by Company (2018-2024)
Table 32. Global Market GABA Receptor Agonist Drug Price by Company (2018-2024) & (USD/Pcs)
Table 33. Global GABA Receptor Agonist Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global GABA Receptor Agonist Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in GABA Receptor Agonist Drug as of 2022)
Table 36. Date of Key Manufacturers Enter into GABA Receptor Agonist Drug Market
Table 37. Key Manufacturers GABA Receptor Agonist Drug Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global GABA Receptor Agonist Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global GABA Receptor Agonist Drug Sales by Region (2018-2024) & (K Pcs)
Table 41. Global GABA Receptor Agonist Drug Sales Market Share in Volume by Region (2018-2024)
Table 42. Global GABA Receptor Agonist Drug Sales by Region (2018-2024) & (US$ Million)
Table 43. Global GABA Receptor Agonist Drug Sales Market Share in Value by Region (2018-2024)
Table 44. Global GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 45. Global GABA Receptor Agonist Drug Sales by Region (2024-2034) & (K Pcs)
Table 46. Global GABA Receptor Agonist Drug Sales Market Share in Volume by Region (2024-2034)
Table 47. Global GABA Receptor Agonist Drug Sales by Region (2024-2034) & (US$ Million)
Table 48. Global GABA Receptor Agonist Drug Sales Market Share in Value by Region (2024-2034)
Table 49. Global GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 50. Global GABA Receptor Agonist Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global GABA Receptor Agonist Drug Sales by Application (2018-2024) & (K Pcs)
Table 52. Global GABA Receptor Agonist Drug Sales Market Share in Volume by Application (2018-2024)
Table 53. Global GABA Receptor Agonist Drug Sales by Application (2018-2024) & (US$ Million)
Table 54. Global GABA Receptor Agonist Drug Sales Market Share in Value by Application (2018-2024)
Table 55. Global GABA Receptor Agonist Drug Price by Application (2018-2024) & (USD/Pcs)
Table 56. Global GABA Receptor Agonist Drug Sales by Application (2024-2034) & (K Pcs)
Table 57. Global GABA Receptor Agonist Drug Sales Market Share in Volume by Application (2024-2034)
Table 58. Global GABA Receptor Agonist Drug Sales by Application (2024-2034) & (US$ Million)
Table 59. Global GABA Receptor Agonist Drug Sales Market Share in Value by Application (2024-2034)
Table 60. Global GABA Receptor Agonist Drug Price by Application (2024-2034) & (USD/Pcs)
Table 61. North America GABA Receptor Agonist Drug Sales by Application (2018-2024) (K Pcs)
Table 62. North America GABA Receptor Agonist Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe GABA Receptor Agonist Drug Sales by Application (2018-2024) (K Pcs)
Table 64. Europe GABA Receptor Agonist Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific GABA Receptor Agonist Drug Sales by Application (2018-2024) (K Pcs)
Table 66. Asia-Pacific GABA Receptor Agonist Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America GABA Receptor Agonist Drug Sales by Application (2018-2024) (K Pcs)
Table 68. Latin America GABA Receptor Agonist Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa GABA Receptor Agonist Drug Sales by Application (2018-2024) (K Pcs)
Table 70. Middle East and Africa GABA Receptor Agonist Drug Sales by Application (2018-2024) & (US$ Million)
Table 71. North America GABA Receptor Agonist Drug Sales by Country (2018-2024) & (K Pcs)
Table 72. North America GABA Receptor Agonist Drug Sales Market Share in Volume by Country (2018-2024)
Table 73. North America GABA Receptor Agonist Drug Sales by Country (2018-2024) & (US$ Million)
Table 74. North America GABA Receptor Agonist Drug Sales Market Share in Value by Country (2018-2024)
Table 75. North America GABA Receptor Agonist Drug Sales by Country (2024-2034) & (K Pcs)
Table 76. North America GABA Receptor Agonist Drug Sales Market Share in Volume by Country (2024-2034)
Table 77. North America GABA Receptor Agonist Drug Sales by Country (2024-2034) & (US$ Million)
Table 78. North America GABA Receptor Agonist Drug Sales Market Share in Value by Country (2024-2034)
Table 79. Europe GABA Receptor Agonist Drug Sales by Country (2018-2024) & (K Pcs)
Table 80. Europe GABA Receptor Agonist Drug Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe GABA Receptor Agonist Drug Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe GABA Receptor Agonist Drug Sales Market Share in Value by Country (2018-2024)
Table 83. Europe GABA Receptor Agonist Drug Sales by Country (2024-2034) & (K Pcs)
Table 84. Europe GABA Receptor Agonist Drug Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe GABA Receptor Agonist Drug Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe GABA Receptor Agonist Drug Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific GABA Receptor Agonist Drug Sales by Region (2018-2024) & (K Pcs)
Table 88. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific GABA Receptor Agonist Drug Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific GABA Receptor Agonist Drug Sales by Region (2024-2034) & (K Pcs)
Table 92. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific GABA Receptor Agonist Drug Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America GABA Receptor Agonist Drug Sales by Country (2018-2024) & (K Pcs)
Table 96. Latin America GABA Receptor Agonist Drug Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America GABA Receptor Agonist Drug Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America GABA Receptor Agonist Drug Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America GABA Receptor Agonist Drug Sales by Country (2024-2034) & (K Pcs)
Table 100. Latin America GABA Receptor Agonist Drug Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America GABA Receptor Agonist Drug Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America GABA Receptor Agonist Drug Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa GABA Receptor Agonist Drug Sales by Country (2018-2024) & (K Pcs)
Table 104. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa GABA Receptor Agonist Drug Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa GABA Receptor Agonist Drug Sales by Country (2024-2034) & (K Pcs)
Table 108. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa GABA Receptor Agonist Drug Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share in Value by Country (2024-2034)
Table 111. Advicenne Company Information
Table 112. Advicenne Introduction and Business Overview
Table 113. Advicenne GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 114. Advicenne GABA Receptor Agonist Drug Product
Table 115. Advicenne Recent Development
Table 116. AstraZeneca Company Information
Table 117. AstraZeneca Introduction and Business Overview
Table 118. AstraZeneca GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 119. AstraZeneca GABA Receptor Agonist Drug Product
Table 120. AstraZeneca Recent Development
Table 121. Athena Drug Delivery Solutions Company Information
Table 122. Athena Drug Delivery Solutions Introduction and Business Overview
Table 123. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 124. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product
Table 125. Athena Drug Delivery Solutions Recent Development
Table 126. Biocodex Company Information
Table 127. Biocodex Introduction and Business Overview
Table 128. Biocodex GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 129. Biocodex GABA Receptor Agonist Drug Product
Table 130. Biocodex Recent Development
Table 131. Elan Corporation Company Information
Table 132. Elan Corporation Introduction and Business Overview
Table 133. Elan Corporation GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 134. Elan Corporation GABA Receptor Agonist Drug Product
Table 135. Elan Corporation Recent Development
Table 136. Eli Lilly and Company Company Information
Table 137. Eli Lilly and Company Introduction and Business Overview
Table 138. Eli Lilly and Company GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 139. Eli Lilly and Company GABA Receptor Agonist Drug Product
Table 140. Eli Lilly and Company Recent Development
Table 141. H.LundBeck, Merck and Co Company Information
Table 142. H.LundBeck, Merck and Co Introduction and Business Overview
Table 143. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 144. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product
Table 145. H.LundBeck, Merck and Co Recent Development
Table 146. GlaxoSmithKline Company Information
Table 147. GlaxoSmithKline Introduction and Business Overview
Table 148. GlaxoSmithKline GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 149. GlaxoSmithKline GABA Receptor Agonist Drug Product
Table 150. GlaxoSmithKline Recent Development
Table 151. NovaDel Pharma Company Information
Table 152. NovaDel Pharma Introduction and Business Overview
Table 153. NovaDel Pharma GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 154. NovaDel Pharma GABA Receptor Agonist Drug Product
Table 155. NovaDel Pharma Recent Development
Table 156. Novartis Company Information
Table 157. Novartis Introduction and Business Overview
Table 158. Novartis GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 159. Novartis GABA Receptor Agonist Drug Product
Table 160. Novartis Recent Development
Table 161. OVATION Pharmaceuticals Company Information
Table 162. OVATION Pharmaceuticals Introduction and Business Overview
Table 163. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 164. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product
Table 165. OVATION Pharmaceuticals Recent Development
Table 166. Osmotica Pharmaceutical Company Information
Table 167. Osmotica Pharmaceutical Introduction and Business Overview
Table 168. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 169. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product
Table 170. Osmotica Pharmaceutical Recent Development
Table 171. Pfizer Company Information
Table 172. Pfizer Introduction and Business Overview
Table 173. Pfizer GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 174. Pfizer GABA Receptor Agonist Drug Product
Table 175. Pfizer Recent Development
Table 176. sanofi-aventis Company Information
Table 177. sanofi-aventis Introduction and Business Overview
Table 178. sanofi-aventis GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 179. sanofi-aventis GABA Receptor Agonist Drug Product
Table 180. sanofi-aventis Recent Development
Table 181. VIVUS Company Information
Table 182. VIVUS Introduction and Business Overview
Table 183. VIVUS GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 184. VIVUS GABA Receptor Agonist Drug Product
Table 185. VIVUS Recent Development
Table 186. XenoPort Company Information
Table 187. XenoPort Introduction and Business Overview
Table 188. XenoPort GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 189. XenoPort GABA Receptor Agonist Drug Product
Table 190. XenoPort Recent Development
Table 191. Key Raw Materials Lists
Table 192. Raw Materials Key Suppliers Lists
Table 193. GABA Receptor Agonist Drug Market Trends
Table 194. GABA Receptor Agonist Drug Market Drivers
Table 195. GABA Receptor Agonist Drug Market Challenges
Table 196. GABA Receptor Agonist Drug Market Restraints
Table 197. GABA Receptor Agonist Drug Distributors List
Table 198. GABA Receptor Agonist Drug Downstream Customers
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
List of Figures
Figure 1. GABA Receptor Agonist Drug Product Picture
Figure 2. Global GABA Receptor Agonist Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global GABA Receptor Agonist Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global GABA Receptor Agonist Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Bamaluzole
Figure 6. Global Bamaluzole Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Phenibut
Figure 8. Global Phenibut Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Baclofen
Figure 10. Global Baclofen Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Gaboxadol
Figure 12. Global Gaboxadol Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Klonopin (clonazepam)
Figure 14. Global Klonopin (clonazepam) Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of Tiagbine
Figure 16. Global Tiagbine Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Global GABA Receptor Agonist Drug Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global GABA Receptor Agonist Drug Sales Market Share by Type in 2022 & 2034
Figure 19. North America GABA Receptor Agonist Drug Sales Market Share in Volume by Type in 2022
Figure 20. North America GABA Receptor Agonist Drug Sales Market Share in Value by Type in 2022
Figure 21. Europe GABA Receptor Agonist Drug Sales Market Share in Volume by Type in 2022
Figure 22. Europe GABA Receptor Agonist Drug Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share in Value by Type in 2022
Figure 25. Latin America GABA Receptor Agonist Drug Sales Market Share in Volume by Type in 2022
Figure 26. Latin America GABA Receptor Agonist Drug Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by GABA Receptor Agonist Drug Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by GABA Receptor Agonist Drug Revenue in 2022
Figure 31. GABA Receptor Agonist Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Attention Deficit Hyperactivity Disorder (ADHD)
Figure 33. Global Attention Deficit Hyperactivity Disorder (ADHD) Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Psychiatric Disorders and Depression
Figure 35. Global Psychiatric Disorders and Depression Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Alzheimer
Figure 37. Global Alzheimer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Epilepsy and Seizure
Figure 39. Global Epilepsy and Seizure Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Product Picture of Anxiety and Sleep Disorders
Figure 41. Global Anxiety and Sleep Disorders Sales YoY Growth (2018-2034) & (K Pcs)
Figure 42. Product Picture of Obesity and Alcoholism
Figure 43. Global Obesity and Alcoholism Sales YoY Growth (2018-2034) & (K Pcs)
Figure 44. Global GABA Receptor Agonist Drug Sales by Application (2018-2034) & (US$ Million)
Figure 45. Global GABA Receptor Agonist Drug Sales Market Share by Application in 2022 & 2034
Figure 46. North America GABA Receptor Agonist Drug Sales Market Share in Volume by Application in 2022
Figure 47. North America GABA Receptor Agonist Drug Sales Market Share in Value by Application in 2022
Figure 48. Europe GABA Receptor Agonist Drug Sales Market Share in Volume by Application in 2022
Figure 49. Europe GABA Receptor Agonist Drug Sales Market Share in Value by Application in 2022
Figure 50. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share in Volume by Application in 2022
Figure 51. Asia-Pacific GABA Receptor Agonist Drug Sales Market Share in Value by Application in 2022
Figure 52. Latin America GABA Receptor Agonist Drug Sales Market Share in Volume by Application in 2022
Figure 53. Latin America GABA Receptor Agonist Drug Sales Market Share in Value by Application in 2022
Figure 54. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share in Value by Application in 2022
Figure 55. Key Raw Materials Price
Figure 56. GABA Receptor Agonist Drug Manufacturing Cost Structure
Figure 57. GABA Receptor Agonist Drug Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries